Literature DB >> 26421392

The phenotypic spectrum of progressive supranuclear palsy.

G Respondek1, G U Höglinger2.   

Abstract

Traditionally, the clinical picture of progressive supranuclear palsy (PSP) was defined by early postural instability with falls, supranuclear vertical gaze palsy, symmetric akinesia and rigidity, frontal and subcortical dementia, and pseudobulbar palsy, leading to death after a mean disease duration of approximately six years. A definite diagnosis of PSP depends on neuropathological confirmation. In recent years, clinico-pathological studies have drawn attention to various "atypical" clinical manifestations of PSP. In these, a clinical diagnosis of PSP is delayed or never accomplished. Comprehensive understanding of the natural history of PSP is required to permit an early and accurate diagnosis. Based on current evidence, this review provides an update on the clinical spectrum of PSP.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Phenotypes; Progressive supranuclear palsy PSP; Tauopathy

Mesh:

Year:  2015        PMID: 26421392     DOI: 10.1016/j.parkreldis.2015.09.041

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  29 in total

1.  Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.

Authors:  Farwa Ali; Peter R Martin; Hugo Botha; J Eric Ahlskog; James H Bower; Joseph Y Masumoto; Demetrius Maraganore; Anhar Hassan; Scott Eggers; Bradley F Boeve; David S Knopman; Daniel Drubach; Ronald C Petersen; Erika Driver Dunkley; Jay van Gerpen; Ryan Uitti; Jennifer L Whitwell; Dennis W Dickson; Keith A Josephs
Journal:  Mov Disord       Date:  2019-02-06       Impact factor: 10.338

Review 2.  Differentiation of atypical Parkinson syndromes.

Authors:  Günter U Höglinger; Jan Kassubek; Ilona Csoti; Reinhard Ehret; Heinz Herbst; Ingmar Wellach; Jürgen Winkler; Wolfgang H Jost
Journal:  J Neural Transm (Vienna)       Date:  2017-02-27       Impact factor: 3.575

3.  Pathological laughter as onset symptom in atypical parkinsonisms.

Authors:  Anna De Rosa; Sabina Pappatà; Silvio Peluso; Francesco Saccà; Maria Lieto; Alessandro Filla; Giuseppe De Michele
Journal:  J Neurol       Date:  2016-11-24       Impact factor: 4.849

Review 4.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

5.  MRI gray and white matter measures in progressive supranuclear palsy and corticobasal syndrome.

Authors:  Neeraj Upadhyay; Antonio Suppa; Maria Cristina Piattella; Matteo Bologna; Flavio Di Stasio; Alessandra Formica; Francesca Tona; Carlo Colosimo; Alfredo Berardelli; Patrizia Pantano
Journal:  J Neurol       Date:  2016-07-13       Impact factor: 4.849

6.  Depressive Symptoms are Frequent in Atypical Parkinsonian Disorders.

Authors:  Leonardo Almeida; Bilal Ahmed; Roger Walz; Sol De Jesus; Addie Patterson; Daniel Martinez-Ramirez; David Vaillancourt; Dawn Bowers; Herbert Ward; Michael S Okun; Nikolaus R McFarland
Journal:  Mov Disord Clin Pract       Date:  2016-06-24

7.  Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration.

Authors:  Monica Sanchez-Contreras; Michael G Heckman; Pawel Tacik; Nancy Diehl; Patricia H Brown; Alexandra I Soto-Ortolaza; Elizabeth A Christopher; Ronald L Walton; Owen A Ross; Lawrence I Golbe; Neill Graff-Radford; Zbigniew K Wszolek; Dennis W Dickson; Rosa Rademakers
Journal:  Mov Disord       Date:  2016-10-06       Impact factor: 10.338

8.  Progressive Supranuclear Palsy and Corticobasal Degeneration.

Authors:  David G Coughlin; Dennis W Dickson; Keith A Josephs; Irene Litvan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 9.  Dyskinesia in multiple system atrophy and progressive supranuclear palsy.

Authors:  Wolfgang H Jost; Paul Lingor; Lars Tönges; Johannes Schwarz; Carsten Buhmann; Jan Kassubek; Anette Schrag
Journal:  J Neural Transm (Vienna)       Date:  2019-05-13       Impact factor: 3.575

10.  Progressive Supranuclear Palsy and Statin Use.

Authors:  Ece Bayram; Connie Marras; David G Standaert; Benzi M Kluger; Yvette M Bordelon; David R Shprecher; Irene Litvan
Journal:  Mov Disord       Date:  2020-03-27       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.